Related Experiment Video
Updated: Jul 3, 2026
07:48
Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis
Published on: January 7, 2019
alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment
1The Adhesion and Angiogenesis Group, Centre for Tumor Biology, Cancer Research UK Clinical Centre, UK. Kairbaan.Hodivala-Dilke@cancer.org.uk
Current Opinion in Cell Biology
|July 22, 2008
Summary
Integrins, like alphavbeta3, play complex roles in pathological angiogenesis, the formation of new blood vessels. This review clarifies their functions and addresses conflicting research findings.
Area of Science:
- * Integrin signaling in vascular biology and disease.
- * Molecular mechanisms of angiogenesis and cancer progression.
Background:
- * Pathological angiogenesis, crucial in diseases like cancer, involves new blood vessel formation.
- * Adhesion molecules, particularly integrins, are investigated as anti-angiogenic therapeutic targets.
- * The specific role of integrin alphavbeta3 in neovascularization remains complex and debated.
Purpose of the Study:
- * To summarize the known functions of integrin alphavbeta3 in angiogenesis.
- * To address and reconcile conflicting data regarding alphavbeta3's role in neovascularization.
- * To identify outstanding questions and future research directions for alphavbeta3 in angiogenesis.
Main Methods:
- * Literature review and synthesis of existing research on integrin alphavbeta3.
- * Analysis of studies investigating alphavbeta3's involvement in pathological angiogenesis.
- * Critical evaluation of conflicting experimental findings.
Main Results:
- * Integrin alphavbeta3 exhibits diverse and context-dependent roles in angiogenesis.
- * Conflicting data arise from the promiscuous nature of alphavbeta3 and varied experimental models.
- * The precise contribution of alphavbeta3 to pathological neovascularization requires further elucidation.
Conclusions:
- * Understanding integrin alphavbeta3's multifaceted roles is critical for developing targeted anti-angiogenic therapies.
- * Further research is needed to resolve ambiguities and define alphavbeta3's specific functions in disease.
- * Future studies should focus on resolving conflicting findings and exploring novel therapeutic strategies targeting alphavbeta3.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:15Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Overview of Cell-Matrix Interactions
The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...